GLP-1 clinic patient retention: the first 90 days decide your revenue
8 min read · Updated August 2026
In a GLP-1 program, most of the revenue sits after the first visit. A patient who stays engaged through month three is worth several times one who quietly stops at week five, and the difference is rarely clinical. It is communication structure.
This framework maps the touchpoints that keep patients on program, and the signals worth watching for early drop off.
Week one: reduce anxiety and set the frame
New patients expect side effects and are unsure what is normal. Scheduled check ins on day 2 and day 7, with simple guidance and a clear route to reach the clinic, prevent the silent quit that follows an unanswered worry.
Weeks two to six: build the habit loop
Weekly touchpoints that ask for one data point, such as weight or injection completion, do two jobs. They keep the patient accountable and they give the clinic an early warning signal when replies stop.
Refill and titration continuity
Refill gaps are a leading cause of program drop off. Automate reminders ahead of the run out date, and flag any patient who has not booked their titration review so staff intervene before the lapse rather than after it.
Milestones, reviews and referrals
Recognize progress at 30, 60 and 90 days. A milestone message is the natural place to ask for a review or a referral, because the patient is experiencing the result rather than being asked at random.
Watch these drop off signals
Retention work becomes proactive once you monitor a small set of signals and route each to a specific action.
- No reply to two consecutive check ins
- Missed follow up appointment with no reschedule
- Refill window passed without contact
- Reported side effects with no clinical follow up logged
- No weight or adherence data for 14 days